复方川芎嗪抗胃癌的网络药理学研究

目的 利用网络药理学,结合基因功能注释及临床数据分析,探索复方川芎嗪在胃癌中的潜在作用位点以及机制.方法 首先利用SwissTargetPrediction数据库筛选复方川芎嗪的潜在药物作用位点,并结合OMIM和Genecard数据库获取胃癌相关靶点.通过交集分析确定潜在的治疗靶点.随后,利用ClusterProfiler的方法对交集下游靶点进行功能注释.同时,利用TCGA数据库获取胃癌患者的原始数据,进行免疫浸润分析、miRNA分析、关键基因的转录调控分析、基因集富集分析(gene set enrichment analysis,GSEA)、基因集差异分析(gene set variatio...

Full description

Saved in:
Bibliographic Details
Published in四川大学学报(医学版) Vol. 55; no. 5; pp. 1114 - 1122
Main Authors 许威, 邓昭敏, 王辛, 姜昊
Format Journal Article
LanguageChinese
Published 四川大学华西医院消化肝病科衰老与肿瘤研究室疾病分子网络前沿科学中心国家老年疾病临床医学研究中心呼吸和共病全国重点实验室(成都 610041)%四川大学华西医院肿瘤中心腹部肿瘤病房/放疗科(成都 610041) 20.09.2024
Subjects
Online AccessGet full text
ISSN1672-173X
DOI10.12182/20240960503

Cover

Abstract 目的 利用网络药理学,结合基因功能注释及临床数据分析,探索复方川芎嗪在胃癌中的潜在作用位点以及机制.方法 首先利用SwissTargetPrediction数据库筛选复方川芎嗪的潜在药物作用位点,并结合OMIM和Genecard数据库获取胃癌相关靶点.通过交集分析确定潜在的治疗靶点.随后,利用ClusterProfiler的方法对交集下游靶点进行功能注释.同时,利用TCGA数据库获取胃癌患者的原始数据,进行免疫浸润分析、miRNA分析、关键基因的转录调控分析、基因集富集分析(gene set enrichment analysis,GSEA)、基因集差异分析(gene set variation analysis,GSVA)、nomogram模型构建以及全基因组关联研究(genome-wide association studies,GWAS)分析等.结果 通过网络药理学筛选,共发现川芎嗪作用于胃癌有14个潜在治疗靶点.功能注释结果显示,这些靶点主要涉及激素代谢、药物代谢和信号转导等通路.基于log rank检验,关键基因ELANE和MPO的表达在胃癌生存曲线的比较中,差异有统计学意义(P<0.05),并与免疫细胞浸润密切相关.此外,GSEA和GSVA结果提示,ELANE和MPO可能通过多条信号通路影响胃癌的发展.结论 本研究通过综合多种分析方法,揭示了复方川芎嗪可能通过调节潜在靶点ELANE和MPO,以及相关的信号通路,对胃癌起治疗作用.
AbstractList 目的 利用网络药理学,结合基因功能注释及临床数据分析,探索复方川芎嗪在胃癌中的潜在作用位点以及机制.方法 首先利用SwissTargetPrediction数据库筛选复方川芎嗪的潜在药物作用位点,并结合OMIM和Genecard数据库获取胃癌相关靶点.通过交集分析确定潜在的治疗靶点.随后,利用ClusterProfiler的方法对交集下游靶点进行功能注释.同时,利用TCGA数据库获取胃癌患者的原始数据,进行免疫浸润分析、miRNA分析、关键基因的转录调控分析、基因集富集分析(gene set enrichment analysis,GSEA)、基因集差异分析(gene set variation analysis,GSVA)、nomogram模型构建以及全基因组关联研究(genome-wide association studies,GWAS)分析等.结果 通过网络药理学筛选,共发现川芎嗪作用于胃癌有14个潜在治疗靶点.功能注释结果显示,这些靶点主要涉及激素代谢、药物代谢和信号转导等通路.基于log rank检验,关键基因ELANE和MPO的表达在胃癌生存曲线的比较中,差异有统计学意义(P<0.05),并与免疫细胞浸润密切相关.此外,GSEA和GSVA结果提示,ELANE和MPO可能通过多条信号通路影响胃癌的发展.结论 本研究通过综合多种分析方法,揭示了复方川芎嗪可能通过调节潜在靶点ELANE和MPO,以及相关的信号通路,对胃癌起治疗作用.
Abstract_FL Objective To explore the potential role and mechanism of compound tetramethylpyrazine in gastric cancer therapy by using network pharmacology analysis combined with gene function annotation and clinical data analysis.Methods SwissTargetPrediction database was used to screen the potential drug action sites of compound tetramethylpyrazine,and the OMIM and Genecard databases were used in combination to obtain gastric cancer-related targets.Intersection analysis was performed to identify potential therapeutic targets.Subsequently,the method of ClusterProfiler was used to perform functional annotation of the downstream targets of intersection.In addition,The Cancer Genome Atlas(TCGA)database was used to obtain the original data of gastric cancer patients,and the immune infiltration analysis,miRNA analysis,transcriptional regulation analysis of key genes,gene set enrichment analysis(GSEA),gene set variation analysis(GSVA),nomogram model construction,and genome-wide association studies(GWAS)were performed.Results Through network pharmacological screening,we found 14 potential therapeutic targets through which tetramethylpyrazine acted on gastric cancer.Functional annotation showed that these targets were mainly involved in the pathways for hormone metabolism,drug metabolism,and signal transduction.Based on log rank test,the expression of the key genes,ELANE and MPO,showed significant difference in the comparison of gastric cancer survival curves(P<0.05),and were closely associated with immune cell infiltration.In addition,GSEA and GSVA results suggested that ELANE and MPO might influence the development of gastric cancer through multiple signaling pathways.Conclusion In this study,by using multiple analysis methods in an integrated way,we found that ligustrazine may have therapeutic effects on gastric cancer by regulating the potential targets of ELANE and MPO,as well as the relevant signaling pathways.
Author 许威
姜昊
邓昭敏
王辛
AuthorAffiliation 四川大学华西医院消化肝病科衰老与肿瘤研究室疾病分子网络前沿科学中心国家老年疾病临床医学研究中心呼吸和共病全国重点实验室(成都 610041)%四川大学华西医院肿瘤中心腹部肿瘤病房/放疗科(成都 610041)
AuthorAffiliation_xml – name: 四川大学华西医院消化肝病科衰老与肿瘤研究室疾病分子网络前沿科学中心国家老年疾病临床医学研究中心呼吸和共病全国重点实验室(成都 610041)%四川大学华西医院肿瘤中心腹部肿瘤病房/放疗科(成都 610041)
Author_FL XU Wei
DENG Zhaomin
JIANG Hao
WANG Xin
Author_FL_xml – sequence: 1
  fullname: XU Wei
– sequence: 2
  fullname: DENG Zhaomin
– sequence: 3
  fullname: WANG Xin
– sequence: 4
  fullname: JIANG Hao
Author_xml – sequence: 1
  fullname: 许威
– sequence: 2
  fullname: 邓昭敏
– sequence: 3
  fullname: 王辛
– sequence: 4
  fullname: 姜昊
BookMark eNotj81Kw0AURmdRwVq78yVcRO-dSW5mllL8g0I3Cu7KTJLxlxQMYlxXXBQrCtKiKLgQQUHcKSI-Tjp5DIO6OosPzseZYbW0lyaMzSEsIEfJFzlwHxRBAKLG6kgh9zAUW9OsmWW7BgARhJJhnUHxOJyMPouP-3JwUYxfJoNx2e-7m3N3e-q-r9zXXTl8c5dnxeuTe7h2z--zbMrqgyxp_rPBNleWN1prXruzut5aansZgg9eJHRERpIME6sFApnEoFCWAop9jBIlwFJMhAo0KY2m2oETN74NLA-kaLD5P--xTq1Ot7t7vaPDtHrs7uQn-3Gem9_GAKqSH50TV0o
ContentType Journal Article
Copyright Copyright © Wanfang Data Co. Ltd. All Rights Reserved.
Copyright_xml – notice: Copyright © Wanfang Data Co. Ltd. All Rights Reserved.
DBID 2B.
4A8
92I
93N
PSX
TCJ
DOI 10.12182/20240960503
DatabaseName Wanfang Data Journals - Hong Kong
WANFANG Data Centre
Wanfang Data Journals
万方数据期刊 - 香港版
China Online Journals (COJ)
China Online Journals (COJ)
DatabaseTitleList
DeliveryMethod fulltext_linktorsrc
DocumentTitle_FL Network Pharmacology Study of Compound Ligustrazine in Gastric Cancer Therapy
EndPage 1122
ExternalDocumentID hxykdxxb202405010
GrantInformation_xml – fundername: (国家自然科学基金); (国家重点研发计划); (四川省科技计划); (四川省干部保健科研项目); (四川大学华西医院学科卓越发展工程项目); (国家老年疾病临床医学研究中心
  funderid: (国家自然科学基金); (国家重点研发计划); (四川省科技计划); (四川省干部保健科研项目); (四川大学华西医院学科卓越发展工程项目); (四川大学华西医院立项资助)
GroupedDBID -05
2B.
4A8
5XA
5XF
92I
93N
ALMA_UNASSIGNED_HOLDINGS
CCEZO
CIEJG
PSX
RPM
TCJ
U1G
U5O
ID FETCH-LOGICAL-s1040-c3ac6b8687efa3106beb139f656d41ce930f6d66190a69a1bbeb0262b4f5f2583
ISSN 1672-173X
IngestDate Thu May 29 04:01:34 EDT 2025
IsPeerReviewed false
IsScholarly true
Issue 5
Keywords Ligustrazine
胃癌
复方川芎嗪
MPO
Gastric cancer
ELANE
Language Chinese
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-s1040-c3ac6b8687efa3106beb139f656d41ce930f6d66190a69a1bbeb0262b4f5f2583
PageCount 9
ParticipantIDs wanfang_journals_hxykdxxb202405010
PublicationCentury 2000
PublicationDate 2024-09-20
PublicationDateYYYYMMDD 2024-09-20
PublicationDate_xml – month: 09
  year: 2024
  text: 2024-09-20
  day: 20
PublicationDecade 2020
PublicationTitle 四川大学学报(医学版)
PublicationTitle_FL Journal of Sichuan University(Medical Sciences)
PublicationYear 2024
Publisher 四川大学华西医院消化肝病科衰老与肿瘤研究室疾病分子网络前沿科学中心国家老年疾病临床医学研究中心呼吸和共病全国重点实验室(成都 610041)%四川大学华西医院肿瘤中心腹部肿瘤病房/放疗科(成都 610041)
Publisher_xml – name: 四川大学华西医院消化肝病科衰老与肿瘤研究室疾病分子网络前沿科学中心国家老年疾病临床医学研究中心呼吸和共病全国重点实验室(成都 610041)%四川大学华西医院肿瘤中心腹部肿瘤病房/放疗科(成都 610041)
SSID ssib001103987
ssib000948209
ssib051370877
ssib000970525
ssib002039726
ssib001186719
ssib051810681
ssib009993695
ssib006703882
ssj0001742280
ssib002263209
Score 2.4312704
Snippet 目的 利用网络药理学,结合基因功能注释及临床数据分析,探索复方川芎嗪在胃癌中的潜在作用位点以及机制.方法 首先利用SwissTargetPrediction数据库筛选复方川芎嗪的潜在药...
SourceID wanfang
SourceType Aggregation Database
StartPage 1114
Title 复方川芎嗪抗胃癌的网络药理学研究
URI https://d.wanfangdata.com.cn/periodical/hxykdxxb202405010
Volume 55
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
journalDatabaseRights – providerCode: PRVAQN
  databaseName: PubMed Central
  issn: 1672-173X
  databaseCode: RPM
  dateStart: 20210101
  customDbUrl:
  isFulltext: true
  dateEnd: 99991231
  titleUrlDefault: https://www.ncbi.nlm.nih.gov/pmc/
  omitProxy: true
  ssIdentifier: ssj0001742280
  providerName: National Library of Medicine
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3Na9RAFA9Fe_AiiorfFHFOsjqZZL6Omd0sxYOnFnoryWZjQahgW6i9VjwUKwpiURQ8iKAg3hQR_5zt9s_wvbfZZOouUkVYltl5b-Z9_F6y7w2ZSRBch4RNFnghQbzoVmxz2zIF161Ml5i_Fzbq0Wmfd9T8Ynx7SS7NzM56Ty1trOc3e1tT95X8C6rQB7jiLtm_QLaeFDqgDfjCNyAM30fCmKWSJZAMdliqmFXMWexxmlnoMcwkzKTYYzVLEuSBHmgjKcJPCpyWmTY1gDnGhuswG1LDMdsm5g5LusTDmVEkFHoU9iScWRqVWOaUn-mSXIefRiXSNtHeDHWDdEskS7vMtZkxSALFnDskzlgijXjqJQzUMUmZo0EJ6Bs2FBggmI3IQQYnwgZM3W1YNHrJOJzFpaBwQ5GoLPqABpvEXyIRMT7PIXgd1Ec1GLyJqBi01nU9Oy2CkQiU5lTjAsAVMRA0oUb8jCSPa8IJ5gmZ48QD8EBPjJ4YiYBRboScQU0mACPF0oqEAZR6IiTqUOMN2E8JDkmQkFfdWFalWG0y6ZOQN4ABw44c5TqVdKc85SUGsZuqD82DJOBJMFymhsjvBk6VHmIAYYNXUWMFXQYSBbnwsBMophqdwV5NJmtyr62ssCmS4DIbzTPyqjAU2Ya8Z1G669xQeHwiJBCWCfn_gmYS7EnLDZlnK1XQqmkhUllOegNJdCn-4zEYim4hY5j_bKGX8igtWqGmt3LXOdHo6Ozq3i-9BAdSo9hLlqFaE1MTMXwxBG42wyMUrcJDp5qEs34MeGXz4b1iczMnLkk7ZY8LyM74xKprDIWKXxZqfP1mU_bh8yxemRnSqZ1e2Qdk7S-j4EsqvPmUxjOxmjIPiuZINecVyDDSeG5q89uEXFX79WktX-NBirT3fuzMao8VuuGW5wTaGrpaZqt3vSpm4VRwslp-mEtG_yWng5mtlTMBH7zf3X_5ffDt7cHO08Hep_2dvYPt7eGrJ8PXj4Y_nw9_vDnY_TJ89njw-cPw3Yvhx69ng8VuutCeb1Vv0mmthfjIeC_Keio3yuh-mUFBr3JI0SNbQjFfxGGvbyNeqgJKNcszZbMwBzoXSuRxKUshTXQuOLZ6f7V_PpjjYVEaHvdzxfM4NlmuCpGrWPVjy20m5YXgWmXhcvVPubY8gfPFozBdCk40N_PLwbH1Bxv9K1ABrudXKTx-AW2pHD8
linkProvider National Library of Medicine
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=%E5%A4%8D%E6%96%B9%E5%B7%9D%E8%8A%8E%E5%97%AA%E6%8A%97%E8%83%83%E7%99%8C%E7%9A%84%E7%BD%91%E7%BB%9C%E8%8D%AF%E7%90%86%E5%AD%A6%E7%A0%94%E7%A9%B6&rft.jtitle=%E5%9B%9B%E5%B7%9D%E5%A4%A7%E5%AD%A6%E5%AD%A6%E6%8A%A5%EF%BC%88%E5%8C%BB%E5%AD%A6%E7%89%88%EF%BC%89&rft.au=%E8%AE%B8%E5%A8%81&rft.au=%E9%82%93%E6%98%AD%E6%95%8F&rft.au=%E7%8E%8B%E8%BE%9B&rft.au=%E5%A7%9C%E6%98%8A&rft.date=2024-09-20&rft.pub=%E5%9B%9B%E5%B7%9D%E5%A4%A7%E5%AD%A6%E5%8D%8E%E8%A5%BF%E5%8C%BB%E9%99%A2%E6%B6%88%E5%8C%96%E8%82%9D%E7%97%85%E7%A7%91%E8%A1%B0%E8%80%81%E4%B8%8E%E8%82%BF%E7%98%A4%E7%A0%94%E7%A9%B6%E5%AE%A4%E7%96%BE%E7%97%85%E5%88%86%E5%AD%90%E7%BD%91%E7%BB%9C%E5%89%8D%E6%B2%BF%E7%A7%91%E5%AD%A6%E4%B8%AD%E5%BF%83%E5%9B%BD%E5%AE%B6%E8%80%81%E5%B9%B4%E7%96%BE%E7%97%85%E4%B8%B4%E5%BA%8A%E5%8C%BB%E5%AD%A6%E7%A0%94%E7%A9%B6%E4%B8%AD%E5%BF%83%E5%91%BC%E5%90%B8%E5%92%8C%E5%85%B1%E7%97%85%E5%85%A8%E5%9B%BD%E9%87%8D%E7%82%B9%E5%AE%9E%E9%AA%8C%E5%AE%A4%28%E6%88%90%E9%83%BD+610041%29%25%E5%9B%9B%E5%B7%9D%E5%A4%A7%E5%AD%A6%E5%8D%8E%E8%A5%BF%E5%8C%BB%E9%99%A2%E8%82%BF%E7%98%A4%E4%B8%AD%E5%BF%83%E8%85%B9%E9%83%A8%E8%82%BF%E7%98%A4%E7%97%85%E6%88%BF%2F%E6%94%BE%E7%96%97%E7%A7%91%28%E6%88%90%E9%83%BD+610041%29&rft.issn=1672-173X&rft.volume=55&rft.issue=5&rft.spage=1114&rft.epage=1122&rft_id=info:doi/10.12182%2F20240960503&rft.externalDocID=hxykdxxb202405010
thumbnail_s http://utb.summon.serialssolutions.com/2.0.0/image/custom?url=http%3A%2F%2Fwww.wanfangdata.com.cn%2Fimages%2FPeriodicalImages%2Fhxykdxxb%2Fhxykdxxb.jpg